Aspen Aerogels, Inc. - ASPN STOCK NEWS

Aspen Aerogels (NYSE: ASPN) reported strong Q3 2024 results with revenue of $117.3 million, up 93% year-over-year, led by $90.6 million in Thermal Barrier revenue. The company posted a net loss of $13.0 million, including a $27.5 million one-time charge from convertible note redemption. Gross margins improved to 42%, and Adjusted EBITDA reached $25.4 million.

The company secured significant financing, including a $125 million term loan facility and a conditional commitment from the U.S. Department of Energy for up to $670.6 million. Aspen raised its 2024 outlook to $450 million in revenue, $9 million in net income, and $90 million in Adjusted EBITDA.

Aspen Aerogels, Inc. (NYSE: ASPN) has announced the pricing of a public offering of 4,250,000 shares of its common stock at $20.00 per share. The company expects to raise approximately $85 million in gross proceeds, before deducting underwriting discounts and expenses. Aspen has also granted the underwriters a 30-day option to purchase up to an additional 637,500 shares at the same price.

The offering is set to close on October 23, 2024, subject to customary conditions. Aspen plans to use the net proceeds for working capital, capital expenditures, and general corporate purposes. Goldman Sachs & Co. and Morgan Stanley are acting as joint book-running managers for the offering, which is being made pursuant to a shelf registration statement on Form S-3 filed with the SEC.

Aspen Aerogels (NYSE: ASPN), a technology leader in sustainability and electrification solutions, has announced a public offering of 4,250,000 shares of its common stock. The company plans to grant underwriters a 30-day option to purchase up to an additional 637,500 shares. Goldman Sachs & Co. and Morgan Stanley are acting as joint book-running managers for the offering.

Aspen intends to use the net proceeds for working capital, capital expenditures, and general corporate purposes. The offering is being made pursuant to a shelf registration statement on Form S-3 filed with the SEC. A preliminary prospectus supplement and accompanying prospectus will be available on the SEC's website.

Aspen Aerogels (NYSE: ASPN) has received a conditional commitment from the U.S. Department of Energy for a proposed loan of up to $670.6 million to finance the construction of its second aerogel manufacturing facility in Register, Georgia. The loan, structured as project financing, would fully fund the remaining CAPEX needed to complete the plant. The Register Plant is designed to manufacture PyroThin® aerogel blankets, with an estimated revenue capacity of $1.2B - $1.6B.

Additionally, Aspen announced Q3 2024 preliminary financial results, including revenue of approximately $117 million, a net loss of about $13 million, and Adjusted EBITDA of approximately $25 million. The company's cash and cash equivalents were approximately $113 million as of September 30, 2024.

Aspen Aerogels (NYSE: ASPN) has secured a $125 million term loan and a $100 million revolving credit facility with MidCap Financial. The collateral structure excludes assets related to Aspen's planned second aerogel manufacturing facility in Statesboro, Georgia. Proceeds will be used to fully redeem the company's legacy convertible note and support general corporate purposes. The term loan matures on August 19, 2029.

This transaction aims to reduce Aspen's cost of capital and provide financing flexibility. The collateral structure is optimized to fit into the anticipated structure of a potential debt option for accelerating the construction of the second manufacturing facility. Management views this as a step towards further reducing capital costs and accessing additional liquidity to support profitable revenue growth.

Aspen Aerogels, Inc. (NYSE: ASPN) has appointed Cari Robinson to its Board of Directors, including roles on the Audit Committee and the Nominating, Governance and Sustainability Committee. Robinson, 61, brings extensive experience in strategic communications, crisis management, and corporate governance. Her background includes senior positions at August Strategic Communications, Revlon, Inc., and IBM, where she handled complex legal, financial, and cybersecurity matters. Donald R. Young, President and CEO of Aspen, highlighted Robinson's strategic thinking and business acumen as valuable assets to the company. This appointment aligns with Aspen's commitment to incorporating diverse expertise and perspectives into its leadership team as the company continues to grow in sustainability and electrification solutions.

Aspen Aerogels (NYSE: ASPN) reported record Q2 2024 revenues of $117.8 million, up 25% QoQ and 145% YoY. The company achieved net income of $16.8 million ($0.21 per diluted share) and Adjusted EBITDA of $28.9 million. Key highlights include:

- Thermal Barriers revenue: $80.8 million (+24% QoQ, +540% YoY)
- Energy Industrial revenue: $36.9 million (+27% QoQ, +4% YoY)
- Gross margins improved to 44%
- Cash generated from operations: $6.8 million

Aspen increased its 2024 outlook, projecting revenue over $390 million (+63% YoY), net income exceeding $7 million, and Adjusted EBITDA above $60 million. The company remains positioned to capture additional revenues as automotive OEM customers ramp up production and Energy Industrial product supply increases.

Aspen Aerogels, Inc. (NYSE: ASPN) has announced its upcoming second quarter 2024 earnings release and conference call. The company plans to release its financial results for Q2 2024 on Wednesday, August 7, 2024, after market close. A conference call to discuss these results is scheduled for Thursday, August 8, 2024, at 8:30 a.m. ET.

President & CEO Don Young and CFO & Treasurer Ricardo C. Rodriguez will lead the discussion. Interested parties can join the call by dialing +1 (833) 470-1428 (domestic) or +1 (929) 526-1599 (international) with conference ID '517793'. A live webcast and slide presentation will be available on Aspen's website. A replay will be accessible on the company's Investor Relations section for approximately one year after the call.

Aspen Aerogels (NYSE: ASPN) has confirmed its attendance at the 10th Annual ROTH London Conference, scheduled for June 25-27, 2024, at the Four Seasons Hotel London at Park Lane. The company, recognized for its advancements in sustainability and electrification, will be represented by President & CEO Donald R. Young and CFO & Treasurer Ricardo C. Rodriguez. They will conduct one-on-one and small group meetings with investors on June 26 and 27. Interested parties are encouraged to arrange meetings through their ROTH Capital representative.